ES2154644T3 - Derivados antidepresivos 3-halofenilpiperazinil propil de triazolonas y triazoldionas sustituidas. - Google Patents

Derivados antidepresivos 3-halofenilpiperazinil propil de triazolonas y triazoldionas sustituidas.

Info

Publication number
ES2154644T3
ES2154644T3 ES93401083T ES93401083T ES2154644T3 ES 2154644 T3 ES2154644 T3 ES 2154644T3 ES 93401083 T ES93401083 T ES 93401083T ES 93401083 T ES93401083 T ES 93401083T ES 2154644 T3 ES2154644 T3 ES 2154644T3
Authority
ES
Spain
Prior art keywords
triazoldionas
halofenilpiperazinil
propil
triazolones
antidepressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93401083T
Other languages
English (en)
Inventor
Robert F Mayol
George M Luke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2154644T3 publication Critical patent/ES2154644T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTAN COMPUESTOS DE LA FORMULA I O LAS SALES FARMACEUTICAMENTE ACEPTABLES Y/O LOS HIDRATOS DE LOS MISMOS EN DONDE R ES HALOGENO Y TRIFLUOROMETIL; X ES OXIGENO Y ACETIL; LAS LINEAS SIMPLE Y PUNTEADA REPRESENTAN TANTO UN ENLACE SIMPLE COVALENTE COMO UN ENLACE DOBLE; N ES UN ENTERO ENTRE 2 Y 4; Y Z ES UN HIDROGENO Y LA FORMULA II EN LA QUE R1 ES HIDROGENO, ALCOXIDO C1-C4, HALOGENO Y TRIFLUOROMETIL, LOS COMPUESTOS SON AGENTES PSICOTROPICOS QUE PUEDEN UTILIZARSE COMO ANTIDEPRESIVOS EN VIRTUD DE SU ZONA RECEPTORA QUE UNE PERFILES DE AFINIDAD Y TAMBIEN PUEDE UTILIZARSE EN LA FARMACOLOGIA ANIMAL.
ES93401083T 1992-04-28 1993-04-26 Derivados antidepresivos 3-halofenilpiperazinil propil de triazolonas y triazoldionas sustituidas. Expired - Lifetime ES2154644T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/875,044 US5256664A (en) 1992-04-28 1992-04-28 Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Publications (1)

Publication Number Publication Date
ES2154644T3 true ES2154644T3 (es) 2001-04-16

Family

ID=25365103

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93401083T Expired - Lifetime ES2154644T3 (es) 1992-04-28 1993-04-26 Derivados antidepresivos 3-halofenilpiperazinil propil de triazolonas y triazoldionas sustituidas.

Country Status (10)

Country Link
US (1) US5256664A (es)
EP (1) EP0568437B1 (es)
JP (1) JPH0641095A (es)
AT (1) ATE199253T1 (es)
CA (1) CA2094890C (es)
DE (1) DE69329942T2 (es)
DK (1) DK0568437T3 (es)
ES (1) ES2154644T3 (es)
GR (1) GR3035809T3 (es)
PT (1) PT568437E (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
EP1189616A2 (en) 1999-04-09 2002-03-27 Sepracor Inc. S-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
DE60028955T2 (de) * 1999-04-09 2007-07-05 Sepracor Inc., Marlborough R-hydroxynefazodon
JP3850224B2 (ja) 2001-03-26 2006-11-29 株式会社ジェイテクト 研削加工方法及び数値制御研削盤
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2356450C (en) * 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Also Published As

Publication number Publication date
GR3035809T3 (en) 2001-07-31
CA2094890C (en) 2000-04-11
DE69329942D1 (de) 2001-03-29
DK0568437T3 (da) 2001-04-30
CA2094890A1 (en) 1993-10-29
ATE199253T1 (de) 2001-03-15
US5256664A (en) 1993-10-26
PT568437E (pt) 2001-06-29
JPH0641095A (ja) 1994-02-15
DE69329942T2 (de) 2001-08-16
EP0568437A1 (en) 1993-11-03
EP0568437B1 (en) 2001-02-21

Similar Documents

Publication Publication Date Title
ATE199253T1 (de) Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen
DE69418704D1 (de) Anthranilsäure derivate
CA2194503A1 (en) 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
ATE247654T1 (de) Neue heterozyklische verbindungen
IL100756A0 (en) Imidazole,triazole and tetrazole derivatives,their preparation and pharmaceutical compositions containing them
NO890074L (no) Fremgangsmaate for fremstilling av substituerte pyrrol-, pyrazol- og triazolderivater.
ATE135701T1 (de) Imidazolderivate, starke und selektive angiotensin-ii-rezeptor-antagonisten
DE69725978D1 (de) Chalcon-derivate und medikamente die diese enthalten
HUT68056A (en) Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates
ATE189814T1 (de) Hydroxypyridin-derivate, ihre herstellung und ihre pharmazeutische verwendung
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
PT992509E (pt) Novos derivados macrolidos
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
WO1997027173A3 (en) Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production
DE69328964D1 (de) Arylindazoline und ihre anwendung als herbizide
ATE169015T1 (de) Aminobenzoesäure derivate
ATE91489T1 (de) Heterocyclische propenamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
JPS5562076A (en) Novel 1*2*44triazole derivative
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
EP0919233B8 (en) Therapeutic agent for kidney diseases
SE9901237D0 (sv) Novel use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 568437

Country of ref document: ES